Education
About Us
Working with TipRanks
Follow Us
Maravai Lifesciences Holdings, Inc. (MRVI)
:MRVI
Total Valuation
Maravai Lifesciences Holdings has a market cap or net worth of $894.97M. The enterprise value is $726.02M.
Market Cap$894.97M
Enterprise Value$726.02M
Share Statistics
Maravai Lifesciences Holdings has 145,022,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding145,022,750
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Maravai Lifesciences Holdings’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -24.24%.
Return on Equity (ROE)-0.45
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-24.24%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee454.71K
Profits Per Employee-455.48K
Employee Count570
Asset Turnover0.26
Inventory Turnover3.01
Valuation Ratios
The current PE Ratio of Maravai Lifesciences Holdings is ―. Maravai Lifesciences Holdings’s PEG ratio is -0.31.
PE Ratio―
PS Ratio2.90
PB Ratio2.31
Price to Fair Value2.31
Price to FCF-33.87
Price to Operating Cash Flow-34.40
PEG Ratio-0.31
Income Statement
In the last 12 months, Maravai Lifesciences Holdings had revenue of 259.19M and earned -144.85M in profits. Earnings per share was -1.05.
Revenue259.19M
Gross Profit108.31M
Operating Income-235.62M
Pretax Income-261.48M
Net Income-144.85M
EBITDA-156.92M
Earnings Per Share (EPS)-1.05
Cash Flow
In the last 12 months, operating cash flow was -49.44M and capital expenditures -16.88M, giving a free cash flow of -66.33M billion.
Operating Cash Flow-49.44M
Free Cash Flow-66.33M
Free Cash Flow per Share-0.46
Dividends & Yields
Maravai Lifesciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.75
52-Week Price Change-31.05%
50-Day Moving Average3.12
200-Day Moving Average2.65
Relative Strength Index (RSI)55.63
Average Volume (3m)1.62M
Important Dates
Maravai Lifesciences Holdings upcoming earnings date is Feb 25, 2026, After Close (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateFeb 25, 2026
Ex-Dividend Date―
Financial Position
Maravai Lifesciences Holdings as a current ratio of 7.53, with Debt / Equity ratio of 14.61%
Current Ratio7.53
Quick Ratio6.65
Debt to Market Cap0.21
Net Debt to EBITDA-0.35
Interest Coverage Ratio-4.94
Taxes
In the past 12 months, Maravai Lifesciences Holdings has paid -1.86M in taxes.
Income Tax-1.86M
Effective Tax Rate<0.01
Enterprise Valuation
Maravai Lifesciences Holdings EV to EBITDA ratio is -9.46, with an EV/FCF ratio of -66.92.
EV to Sales5.73
EV to EBITDA-9.46
EV to Free Cash Flow-66.92
EV to Operating Cash Flow198.94
Balance Sheet
Maravai Lifesciences Holdings has $243.57M in cash and marketable securities with $35.85M in debt, giving a net cash position of $207.73M billion.
Cash & Marketable Securities$243.57M
Total Debt$35.85M
Net Cash$207.73M
Net Cash Per Share$1.43
Tangible Book Value Per Share$1.61
Margins
Gross margin is 20.86%, with operating margin of -90.91%, and net profit margin of -55.89%.
Gross Margin20.86%
Operating Margin-90.91%
Pretax Margin-100.89%
Net Profit Margin-55.89%
EBITDA Margin-60.54%
EBIT Margin-82.48%
Analyst Forecast
The average price target for Maravai Lifesciences Holdings is $4.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$4.50
Price Target Upside38.46% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast-30.56%
EPS Growth Forecast48.79%